Evidence Emerges That GSK Bribed China Officials As Early As 2001
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline's compliance problems in China continue to grow as evidence elsewhere around the world indicates the U.K.-based company admitted as early as 2001 that it bribed China officials.